Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Enerzinc is an oral zinc supplement solution developed and marketed by Laboratorios Laproff, a Colombian pharmaceutical company. The product contains zinc sulfate as its active ingredient, formulated at a concentration of 200 mg/100 mL. It is indicated for the treatment and prevention of zinc deficiency, immune system support, and general wellness. Zinc is an essential trace element that serves as a cofactor for numerous enzymes involved in DNA synthesis, protein metabolism, and immune cell proliferation. Enerzinc is available over-the-counter in Colombia in red berry-flavored oral solution presentations of 90 mL and 120 mL.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Enerzinc.